Clinical trial Recruiting at 1 site Early Phase 1 Interventional Ages 18 and up

Evaluating Ketorolac for reducing symptoms after ureteral stent placement

Official title: A Prospective, Randomized, Pilot Study of Preoperative Anti-Inflammatory Therapy for Ureteral Stent Symptoms

Run by Washington University School of Medicine · NCT03638999 · Data updated 2026-11-12

This study is testing if giving a pain medication called Ketorolac before placing a ureteral stent can help reduce discomfort and inflammation for people with kidney stones.

Quick facts

PhaseEarly Phase 1
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment36 (estimated)
SponsorWashington University School of Medicine
Academic / other
Locations1 site (St Louis, Missouri)
StatusRecruiting
StartedJuly 31, 2018
Main results expectedOctober 2026
Study endsOctober 2027
Registry record updatedDecember 22, 2025
Trial IDNCT03638999 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old with renal urolithiasis scheduled for ureteral stent placement.

Probably not a fit

Patients with chronic NSAID use, active urinary tract infections, or those requiring bilateral stone procedures may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study aims to assess the effectiveness of pre-operative intravenous Ketorolac in reducing inflammatory responses and stent-related symptoms in patients undergoing ureteral stent placement due to kidney stones. Eligible participants will be randomly assigned to receive either Ketorolac or a saline control before their procedure. The study will also evaluate the feasibility of recruitment and assessment procedures, alongside measuring plasma inflammatory markers at various stages. Follow-up will include a post-operative check-in to monitor patient recovery and adherence to the protocol.

Why it matters

Potential benefit: If successful, this approach could significantly reduce post-operative discomfort and improve recovery for patients undergoing ureteral stent placement.

How similar studies have gone: While the use of Ketorolac in this specific context is novel, similar studies have shown promise in reducing inflammation and pain in other surgical settings.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Over 18 years of age and willing and able to provide informed consent
* Patients with renal urolithiasis planning to undergo ureteral stent placement following ureteroscopic manipulation

Exclusion Criteria:

* Patients requiring a bilateral stone procedure.
* Patients on a chronic non-steroidal anti-inflammatory drugs (NSAIDs) including Aspirin defined as any NSAIDs use for more than fifteen days within thirty days prior to the procedure. Exception: use of daily Aspirin 81 mg is allowed.
* Patients on any steroid therapy.
* Patients with prescription anti-inflammatory drugs.
* Patients with gastrointestinal ulcers.
* Patients with ureteral obstruction or stricture unrelated to stone disease.
* Patients with active urinary tract infection as evidence of untreated positive urine culture obtained prior to the procedure (as part of pre-operative testing).
* Patients with preexisting indwelling ureteral stent
* Patients who are pregnant or lactating.
* Patients with renal or liver impairment.
* Patients with concurrent disease, infection, or co-morbidity that, in the judgment of the investigator, would render the patient inappropriate for enrollment.

Where it's running

  • Washington University
    St Louis, Missouri, United States
    Recruiting

Study contacts

  • Principal investigator: Alana Desai, MD — Washington University School of Medicine
  • Study coordinator: Alana Desai, MD
  • Email: desaia@email.wustl.edu
  • Phone: (314)

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.